M. Krishna et al., EXPRESSION OF P53 ANTIGEN IN INFLAMED AND REGENERATED MUCOSA IN ULCERATIVE-COLITIS AND CROHNS-DISEASE, Modern pathology, 8(6), 1995, pp. 654-657
Physiologic overexpression of p53 protein may occur in the G1 stage of
the cell cycle to slow down the cell cycle and allow DNA repair in st
ressed or injured cells. We questioned whether there is increased expr
ession of p53 protein in acutely inflamed mucosa (AI) and regenerated
mucosa (RM) in ulcerative colitis (UC) and Crohn's disease (CD). Forma
lin-fixed paraffin-embedded sections of resected bowels from eight pat
ients with UC and 20 with CD were reviewed, and blocks were selected h
aving areas defined as follows: AI = two high-power fields (HPFs) at t
he edge of an ulcer, or one HPF with an inflamed crypt in the center;
RM = branched or irregular glands with only mild chronic inflammation.
Blocks with normal mucosa were available in 20 cases. One case of CD
also had dysplasia, adenoma, and invasive carcinoma. p53 was identifie
d with PAb1801 antibody using a labeled avidin-biotin immunoperoxidase
technique. In each defined area, the positive nuclei were counted and
expressed as the number of positive nuclei per 10 HPFs. Data were ana
lyzed statistically for comparisons within and between the diseases. I
n normal mucosa, only rare cells expressed p53 in two cases of CD. The
mean frequency of positive nuclei was 2.24/10 HPFs in AT and 0.30/10
HPFs in RM in CD, and 7.63/10 HPFs in AT and 1.14/10 HPFs in RM in UC.
Differences between the means for AI and RM were statistically signif
icant in both UC and CD. Although not significant, the frequency of po
sitive staining in both AT and RM was greater in UC as compared with C
D. The results show that p53 expression is increased in areas of acute
inflammation in UC and CD. Decreased expression in RM as compared wit
h AI suggests that expression of p53 is reversible and gene regulation
in these areas is different.